ES2108258T3 - Granulos que contienen sustancias medicamentosas peptidicas y su preparacion asi como su empleo. - Google Patents

Granulos que contienen sustancias medicamentosas peptidicas y su preparacion asi como su empleo.

Info

Publication number
ES2108258T3
ES2108258T3 ES93902032T ES93902032T ES2108258T3 ES 2108258 T3 ES2108258 T3 ES 2108258T3 ES 93902032 T ES93902032 T ES 93902032T ES 93902032 T ES93902032 T ES 93902032T ES 2108258 T3 ES2108258 T3 ES 2108258T3
Authority
ES
Spain
Prior art keywords
preparation
well
drug substances
granules containing
peptidic drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93902032T
Other languages
English (en)
Inventor
Jens-Christian Wunderlich
Ursula Schick
Jurgen Werry
Jurgen Freidenreich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfatec Pharma GmbH
Original Assignee
Alfatec Pharma GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4201179A external-priority patent/DE4201179A1/de
Application filed by Alfatec Pharma GmbH filed Critical Alfatec Pharma GmbH
Application granted granted Critical
Publication of ES2108258T3 publication Critical patent/ES2108258T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBEN PELLETS QUE CONTIENEN MEDICAMENTO PEPTIDO INCORPORADO EN UNA MATRIZ CONSISTENTE EN GELATINA O GELATINA FRACCIONADA Y PLASTIFICANTES, DISPONIENDO EL PELLETS DE UNA CONSISTENCIA SEMISOLIDA O SIMILAR AL GEL. TALES FORMAS DE MEDICAMENTO EXHIBEN, DESPUES DE LA APLICACION, PROPIEDADES BIOADHESIVAS Y, EN VIRTUD DE LA MATRIZ DE MATERIALES ESPECIFICADOS, PERMITE O REFUERZA LA REABSORCION DEL MEDICAMENTO PEPTIDO POR EL CUERPO.
ES93902032T 1992-01-17 1993-01-18 Granulos que contienen sustancias medicamentosas peptidicas y su preparacion asi como su empleo. Expired - Lifetime ES2108258T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4201179A DE4201179A1 (de) 1992-01-17 1992-01-17 Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
US87686592A 1992-04-30 1992-04-30

Publications (1)

Publication Number Publication Date
ES2108258T3 true ES2108258T3 (es) 1997-12-16

Family

ID=25911046

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93902032T Expired - Lifetime ES2108258T3 (es) 1992-01-17 1993-01-18 Granulos que contienen sustancias medicamentosas peptidicas y su preparacion asi como su empleo.

Country Status (8)

Country Link
EP (1) EP0621775B1 (es)
AT (1) ATE156350T1 (es)
AU (1) AU3343093A (es)
DE (1) DE59307073D1 (es)
DK (1) DK0621775T3 (es)
ES (1) ES2108258T3 (es)
GR (1) GR3024529T3 (es)
WO (1) WO1993013753A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU679906B2 (en) 1992-01-17 1997-07-17 Alfatec-Pharma Gmbh Solid bodies containing active substances and a structure consisting of hydrophilic macromolecules, plus a method of producing such bodies
AU1677095A (en) * 1994-01-11 1995-08-01 Alkermes Controlled Therapeutics, Inc. Oral dosage form of desmopressin (ddavp)
CA2164262A1 (en) * 1995-12-01 1997-06-02 Charles J. Doillon Biostable porous material comprising composite biopolymers
US5686133A (en) * 1996-01-31 1997-11-11 Port Systems, L.L.C. Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
EP0914141A1 (en) * 1996-04-22 1999-05-12 Peter R. Rothschild Stabilized antihepatitis-b vaccine tablets
IT1293087B1 (it) * 1997-07-10 1999-02-11 Isi Ist Sierovaccinogeno Ital Microparticelle a base di materiali polimerici ibridi per il rilascio controllato di molecole biologicamente attive, procedimento per la
EP0966271A1 (en) * 1997-11-06 1999-12-29 Orbon Corporation Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
DE19821951A1 (de) * 1998-05-15 1999-11-18 Basf Ag Cyclosporin-Zubereitungen
DE10332160A1 (de) 2003-07-15 2005-02-03 Röhm GmbH & Co. KG Multipartikuläre Arzneiform, enthaltend mucoadhaesiv formulierte Peptid- oder Protein-Wirkstoffe, sowie ein Verfahren zur Herstellung der Arzneiform
DE102005054937A1 (de) * 2005-11-17 2007-05-24 Gelita Ag Angiogenese förderndes Substrat
DE102005054938A1 (de) * 2005-11-17 2007-05-24 Gelita Ag Formkörper auf Basis eines vernetzten, Gelatine enthaltenden Materials, Verfahren zu deren Herstellung sowie deren Verwendung
JP2010523554A (ja) 2007-04-04 2010-07-15 シグモイド・ファーマ・リミテッド タクロリムスの医薬組成物
ES2963291T3 (es) 2007-04-26 2024-03-26 Sublimity Therapeutics Ltd Fabricación de múltiples minicápsulas
EP2471518B1 (en) * 2009-05-18 2017-08-23 Sigmoid Pharma Limited Composition comprising oil drops
US9878036B2 (en) 2009-08-12 2018-01-30 Sigmoid Pharma Limited Immunomodulatory compositions comprising a polymer matrix and an oil phase
KR101708086B1 (ko) * 2010-02-25 2017-02-17 에보니크 룀 게엠베하 제약 또는 기능식품 제제
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319792D0 (en) * 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
WO2016071515A1 (en) 2014-11-07 2016-05-12 Sigmoid Pharma Limited Compositions comprising cyclosporin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB887901A (es) * 1960-04-13 1900-01-01
US3312594A (en) * 1963-06-21 1967-04-04 Squibb & Sons Inc Longlasting troche
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
EP0138216B1 (en) * 1983-10-14 1993-01-07 Sumitomo Pharmaceuticals Company, Limited Sustained-release ifn preparation for parenteral administration
EP0179904A1 (en) * 1984-05-09 1986-05-07 Medaphore Inc. Oral insulin and a method of making the same
EP0230647B1 (en) * 1985-12-27 1993-03-31 Sumitomo Pharmaceuticals Company, Limited Method for producing a sustained release formulation
GB8723846D0 (en) * 1987-10-10 1987-11-11 Danbiosyst Ltd Bioadhesive microsphere drug delivery system
GB2237510B (en) * 1989-11-04 1993-09-15 Danbiosyst Uk Small particle drug compositions for nasal administration
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution

Also Published As

Publication number Publication date
EP0621775B1 (de) 1997-08-06
ATE156350T1 (de) 1997-08-15
DK0621775T3 (da) 1997-10-06
WO1993013753A1 (de) 1993-07-22
AU3343093A (en) 1993-08-03
EP0621775A1 (de) 1994-11-02
DE59307073D1 (de) 1997-09-11
GR3024529T3 (en) 1997-12-31

Similar Documents

Publication Publication Date Title
ES2108258T3 (es) Granulos que contienen sustancias medicamentosas peptidicas y su preparacion asi como su empleo.
ES2136662T3 (es) Formas de presentacion farmaceuticas y de otro tipo.
DE69124274D1 (de) Oligopeptide, sie enthaltende pharmazeutische und Futterzusammensetzung und Benützung von Oligopeptiden
AR002754A1 (es) Composición farmacéutica que comprende bacterias lactobacillus viables micro-encapsuladas, y uso de la composición para preparar de un medicamento
ES2189018T3 (es) Utilizacion de polvos de polimeros o granulados de polimeros redispersables para el revestimiento de formas de administracion farmaceuticas o agroquimicas.
ES2177609T3 (es) Pluma de administracion de medicacion con una escala para fijacion de la dosis.
DE69427038D1 (de) Transdermales medikamentenverabreichungssystem
DE3674570D1 (de) N,n-dimethyl-1-(1-(4-chlorophenyl)-cyclobutyl)-3-methylbutylamin-hydrochlorid, monohydrat und pharmazeutische zusammensetzungen, welche diese enthalten.
FI973419A0 (fi) Epäorgaanisten aerogeelien käyttö lääkkeiden valmistuksessa
MX9207334A (es) Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene
ATE204297T1 (de) Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
DE3880212D1 (de) Pharmazeutische zusammensetzung zur hautabsorption und hautabsorptionsverstaerkung von medikamenten.
DE69300913D1 (de) Polymorph Terazosin und pharmazeutische Zusammenstellung.
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DE69409237D1 (de) Orale, pharmazeutische zusammensetzungen das ein protein oder peptide, eine antikoerper und polymerkugeln enthalten
ES2103969T3 (es) Composicion de reactivo en dosis unitaria para dosificados por union especifica.
ES2053528T3 (es) Composicion farmaceutica que comprende un medicamento y un polimero hinchable en agua.
AR021693A1 (es) 4,5-AZOLO-OXINDOLES,COMPOSICIoN FARMACEUTICA QUE LOS CONTIENE,USO DE LOS MISMOS EN LA PREPARACIoN DE MEDICAMENTOS,Y COMPUESTOS INTERMEDIARIOS UTILES EN LA SíNTESIS DE LOS MISMOS.
KR960703572A (ko) 기질-포집 비이드 제제(matrix-entrapped beadlet preparation)
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
BR0113579A (pt) Proteìnas sintéticas modificadas por polìmero
IT8819731A0 (it) Composizioni farmaceutiche contenenti timosina alfa 1.
DE68903389D1 (de) Kautschuk fuer medizinische oder pharmazeutische artikel.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 621775

Country of ref document: ES